REGENEREX PHARMA, INC. Accrued Liabilities
REGENEREX PHARMA, INC. had Accrued Liabilities of $88.27 thousand as of 2025-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent · last filed 2025-06-30
- 2025-03-31: Accrued Liabilities $88.27K.
- 2024-03-31: Accrued Liabilities $97.25K.
- 2023-03-31: Accrued Liabilities $125.79K.
- 2022-03-31: Accrued Liabilities $91.67K.
| Period end | Accrued Liabilities |
|---|---|
| 2025-03-31 | $88.27K 10-K · filed 2025-06-30 |
| 2024-03-31 | $97.25K 10-K · filed 2025-06-30 |
| 2023-03-31 | $125.79K 10-K · filed 2024-06-24 |
| 2022-03-31 | $91.67K 10-K · filed 2023-06-09 |
| 2021-04-15 | $14.00K 10-Q · filed 2021-11-01 |
| 2021-03-31 | $71.00K 10-K · filed 2021-06-23 |
| 2021-03-21 | $71.00K 10-K · filed 2022-06-28 |
| 2020-03-31 | $45.44K 10-K · filed 2021-06-23 |
| 2019-03-31 | $14.78K 10-K/A · filed 2020-08-11 |